Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...
The manufacturer announced this week it had reached a $2.7 billion deal to acquire Kito Crosby Ltd. The all-cash transaction ...
China’s Contemporary Amperex Technology (CATL), the world’s largest producer of batteries for electric vehicles and a supplier for Tesla, has applied for a listing in Hong Kong, setting sights on one ...
Cognition Therapeutics Inc. evolved from the work of a neuroscientist and a chemist working in the San Francisco Bay area, seeking out targets to block the effects of Alzheimer’s disease. Since the ...
Apple’s switch could result in a $7.7 billion revenue impact by FY2028, but Qualcomm's strong non-Apple relationships and ...
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial in patients with relapsed/refractory ...
BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib. The ...
BTIG analyst Justin Zelin downgraded Kura Oncology (KURA) to Neutral from Buy without a price target The firm cites a lack of clarity and ...
The Huawei Mate XT is finally seeing an international release. Huawei will provide more details at its press event on 18.
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Kirin Holdings Co. will release products in Taiwan that contain an ingredient which claims to help maintain immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results